Treatment of severe psoriasis with infliximab
JA Leman, AD BurdenAlan Lyell Centre for Dermatology, Western Infirmary, Glasgow, UKAbstract: Psoriasis is a chronic, immune mediated inflammatory disease characterized by increased cell signalling via cytokines and chemokines on a background of up-regulated gene expression. There is substantial evi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-11-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Online Access: | http://www.dovepress.com/treatment-of-severe-psoriasis-with-infliximab-a2635 |